Research Peptide (Triple Agonist) – 30mg ≥99% Purity for Metabolic Studies
Explore Reta****ide (Reta), a premium synthetic triple receptor agonist peptide targeting GLP-1, GIP, and glucagon receptors. This high-potency research compound enables advanced laboratory investigations into synergistic metabolic pathways, incretin effects, glucagon signaling, energy homeostasis, glucose regulation, and multi-hormone interactions in non-clinical models.
Available as 30mg lyophilized powder in a single vial – ideal for precise dosing in controlled research environments. Visit our main peptide collection for more research-grade compounds.
Why Researchers Choose Our 30mg Peptide
- ≥99% Purity Guaranteed – Confirmed via HPLC and mass spectrometry for reliable, reproducible experimental outcomes.
- Lyophilized Powder Form – Maximizes stability, extends shelf life, and simplifies storage/handling in lab settings.
- Fast, Discreet USA Shipping – 2–3 business days with full tracking included on every order.
- Third-Party Lab Tested – Comprehensive Certificates of Analysis (COAs) available for full transparency and compliance.
- Strictly Research Use Only (RUO) – For in vitro and laboratory studies exclusively – not for human, therapeutic, or veterinary applications.
Learn more about our quality standards on our Peptide Basics homepage.
Key Research Applications for Triple Agonist Peptide
Retatrut*de’s unique multi-receptor activation makes it a powerful tool for studying integrated metabolic mechanisms beyond single-agonist compounds.
- GLP-1, GIP, and Glucagon Receptor Signaling
Examine receptor binding affinities, downstream cascades, crosstalk, and synergistic activation in cell-based or isolated system assays. - Metabolic Regulation and Energy Homeostasis
Investigate glucose uptake, lipid oxidation, insulin sensitivity, and total energy expenditure pathways in relevant models. - Appetite and Satiety Mechanism Studies
Analyze central/peripheral signaling, hunger modulation, and feedback loops involved in feeding behavior research. - Pharmacokinetics and Multi-Receptor Dynamics
Assess stability, half-life, binding kinetics, and cross-receptor interactions under controlled variables. - Models of Metabolic Disorders
Support exploratory work on obesity-related pathways, hepatic lipid mechanisms, and endocrine interactions (non-clinical only).
Reta****ide 30mg Product Specifications
| Specification | Details |
|---|---|
| Peptide Name | Reta****ide (Reta Triple Agonist) |
| Purity | ≥99% (HPLC and mass spectrometry verified) |
| Form | Lyophilized powder |
| Quantity per Vial | 30mg |
| Molecular Structure | Synthetic peptide with fatty diacid conjugation for enhanced stability (research reference only) |
| Storage | Store lyophilized at -20°C; reconstitute as per lab protocols |
| Intended Use | In vitro research and laboratory experimentation only |
Important Product Usage Warning – Research Use Only
This product is sold strictly as a RESEARCH CHEMICAL. It is intended exclusively for in vitro testing, laboratory analysis, and qualified scientific investigation.
All information on this site is provided for educational purposes only. Introduction into humans or animals is prohibited by law. Handle only with appropriate training and in licensed facilities. This is NOT a drug, food, supplement, or cosmetic and must not be misbranded or misused as such.
RUO – RESEARCH USE ONLY • NOT FOR HUMAN OR VETERINARY USE • NOT FOR THERAPEUTIC APPLICATION
